| 201167_X_AT |
ARHGDIA |
Rho GDP dissociation inhibitor (GDI) alpha |
| 202821_S_AT |
LPP |
LIM domain containing preferred translocation partner in lipoma |
| 202875_S_AT |
PBX2 |
pre-B-cell leukemia homeobox 2 |
| 203523_AT |
LSP1 |
lymphocyte-specific protein 1 |
| 203930_S_AT |
MAPT |
microtubule-associated protein tau |
| 204268_AT |
S100A2 |
S100 calcium binding protein A2 |
| 204269_AT |
PIM2 |
pim-2 oncogene |
| 205428_S_AT |
CALB2 |
calbindin 2, 29kDa (calretinin) |
| 206508_AT |
CD70 |
CD70 molecule |
| 206697_S_AT |
HP |
haptoglobin |
| 206994_AT |
CST4 |
cystatin S |
| 207189_S_AT |
ZZEF1 |
zinc finger, ZZ-type with EF-hand domain 1 |
| 207408_AT |
SLC22A14 |
solute carrier family 22 (organic cation transporter), member 14 |
| 207774_AT |
ATG10 |
ATG10 autophagy related 10 homolog (S. cerevisiae) |
| 207949_S_AT |
ICA1 |
islet cell autoantigen 1, 69kDa |
| 209718_AT |
NCAPH2 |
non-SMC condensin II complex, subunit H2 |
| 210280_AT |
MPZ |
myelin protein zero (Charcot-Marie-Tooth neuropathy 1B) |
| 210331_AT |
HECW1 |
HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 |
| 211540_S_AT |
RB1 |
retinoblastoma 1 (including osteosarcoma) |
| 212555_AT |
PRKAR1B |
protein kinase, cAMP-dependent, regulatory, type I, beta |
| 212965_AT |
HIC2 |
hypermethylated in cancer 2 |
| 213791_AT |
PENK |
proenkephalin |
| 214701_S_AT |
FN1 |
fibronectin 1 |
| 215296_AT |
CDC42BPA |
CDC42 binding protein kinase alpha (DMPK-like) |
| 215430_AT |
GK2 |
glycerol kinase 2 |
| 216509_X_AT |
MLLT10 |
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 10 |
| 216837_AT |
EPHA5 |
EPH receptor A5 |
| 217714_X_AT |
STMN1 |
stathmin 1/oncoprotein 18 |
| 219879_S_AT |
C17ORF53 |
|
| 220135_S_AT |
SLC7A9 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 9 |
| 220574_AT |
SEMA6D |
sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6D |
| 220578_AT |
ADAMTSL4 |
ADAMTS-like 4 |
| 221350_AT |
HOXC8 |
homeobox C8 |